An Introduction to Genomics and SAS Scientific Discovery Solutions
|
|
|
- Melina Brown
- 10 years ago
- Views:
Transcription
1 An Introduction to Genomics and SAS Scientific Discovery Solutions Dr Karen M Miller Product Manager Bioinformatics SAS EMEA Copyright 2003, SAS Institute Inc. All rights reserved. 1
2 Overview! SAS Life Sciences! Genomics at SAS! Introduction to Scientific Discovery Solutions Copyright 2003, SAS Institute Inc. All rights reserved. 2
3 SAS Core Competencies Copyright 2003, SAS Institute Inc. All rights reserved. 3
4 SAS Core Competencies Copyright 2003, SAS Institute Inc. All rights reserved. 4
5 SAS Biomedical Intelligent Enterprise CONTINUOUS VALIDATION Patent expiration: 20 years SALES & DISCOVERY DEVELOPMENT MANUFACTURING MARKETING SAS Research Data Management SAS Drug Development SAS Process Intelligence IntelliVisor for Pharma SAS Microarray Solution COLLABORATIVE PROCESS Customer Relationship Management for Pharma Strategic Performance Management Supplier Relationship Management Human Capital Management Patent Discovery Service ADMINISTRATION IT Management Financial Management Risk Management SAS uniquely equipped to deliver integrated solutions that span the entire Life Sciences enterprise Copyright 2003, SAS Institute Inc. All rights reserved. 5
6 SAS Understands Life Sciences! Stable, global company! 26 years of experience in Life Sciences! More than 1000 pharma/biotech customers worldwide! Dedicated resources in R&D, marketing, and sales! FDA standard for e-submission Copyright 2003, SAS Institute Inc. All rights reserved. 6
7 Scientific Discovery Organisation at SAS! Created from a merger of individuals from our longstanding pharma, statistics, and data mining groups! Experts in statistics, computer science, and molecular science and benefits from the years of SAS know-how and skill across multiple industries and technologies! Collaborations with public, commercial, and federal institutions Copyright 2003, SAS Institute Inc. All rights reserved. 7
8 The Need in Scientific Discovery! Data Volumes! Data Visualisation! Data Analysis! Data Regulation Copyright 2003, SAS Institute Inc. All rights reserved. 8
9 The Pains in Scientific Discovery! Cost/ ROI! Time/ROI! Regulatory Compliance Copyright 2003, SAS Institute Inc. All rights reserved. 9
10 The Pains in Scientific Discovery Cost to Develop Drug (PhRMA 2002 Pharmaceutical industry Profile) Copyright 2003, SAS Institute Inc. All rights reserved. 10
11 The Pains in Scientific Discovery Time: approx 14.5 years Traditional linear process Identify drug target Lead discovery Lead Optimization Drug discovery (6-12 yrs) Target validation Drug development (4-6 yrs) Pre-Clinical studies Development Moving to concurrent processes Drug development (3 yrs) Drug discovery (3-5 yrs) Identify drug target Process Goal: Identify failures early Lead discovery Target validation Lead Optimization Pre-Clinical studies Development Copyright 2003, SAS Institute Inc. All rights reserved. 11
12 The Pains in Scientific Discovery! Regulatory Compliance Major Bottleneck New drug launches are erratic: 2001< 25, 2002< 35 Copyright 2003, SAS Institute Inc. All rights reserved. 12
13 Overview! SAS Life Sciences! Genomics at SAS! Introduction to Scientific Discovery Solutions Copyright 2003, SAS Institute Inc. All rights reserved. 13
14 Scientific Discovery and the Central Dogma Transcriptomics Proteomics Copyright 2003, SAS Institute Inc. All rights reserved. 14
15 Computer Science Statistics & Mining SAS Genomics Genetics DNA Sequencers Transcriptomics RNA Microarrays Microtechnological Breakthroughs Proteomics Proteins Mass Spectrometers Copyright 2003, 2002, SAS Institute Inc. Inc. All All rights rights reserved. reserved. 15
16 Genetic Marker Data Copyright 2003, SAS Institute Inc. All rights reserved. 16
17 SAS/Genetics: Simplifying Marker Analyses! Analysts can: Study genetic markers individually Examine the relationship between two or more markers Find associations between markers and traits using case-control or family data Copyright 2003, SAS Institute Inc. All rights reserved. 17
18 SAS /Genetics Copyright 2003, SAS Institute Inc. All rights reserved. 18
19 Computer Science Statistics & Mining SAS Genomics Genetics DNA Sequencers Transcriptomics RNA Microarrays Microtechnological Breakthroughs Proteomics Proteins Mass Spectrometers Copyright 2003, 2002, SAS Institute Inc. Inc. All All rights rights reserved. reserved. 19
20 Scientific Discovery Process: Standardizing innovation Design experiment Experimental Design Generate hypothesis Run experiment Engines AP Library Refine analysis Sharing and Accessibility Analyze Data Visualization Security Share analysis Compare with known data Centralized repository Analytical Processes (AP) Copyright 2003, SAS Institute Inc. All rights reserved. 20
21 SAS Scientific Discovery Solutions: Optimizing Knowledge Exchange Statisticians Biologists Toxicologists Geneticists Anticipate issues Identify synergies Improve success SAS Scientific Discovery Warehousing Analytics Visualization Managers Directors Executives Project 1 Project 2 Project 3 Geneticists Protein Scientists Chemists Toxicologists Copyright 2003, SAS Institute Inc. All rights reserved. 21
22 SAS Scientific Discovery Solutions Data engines Data models Visual n Future solutions Analysis SAS Microarray Solution Proteomics Genetic Markers HTS Cohesive solutions for discovery research Client Server SAS Research Data Management SAS Research Data Management Java Application SAS Technologies (WA) Extendable with other SAS technologies & solutions Enterprise Miner Text Miner SAS/Genetics JMP Copyright 2003, SAS Institute Inc. All rights reserved. 22
23 SAS MicroArray Solution: Bringing Sound Statistical Methods to Array Analyses! Identify related genes with confidence! Achieve repeatability! Standardize across chips, experiments, lab! Promote knowledge sharing-statistician and biologist! Facilitate innovation and evolution Copyright 2003, SAS Institute Inc. All rights reserved. 23
24 SAS MicroArray Solution: Analytical Processes Copyright 2003, SAS Institute Inc. All rights reserved. 24
25 SAS MicroArray Solution: Search Copyright 2003, SAS Institute Inc. All rights reserved. 25
26 SAS MicroArray Solution: Analysis Copyright 2003, SAS Institute Inc. All rights reserved. 26
27 SAS MicroArray Solution: Analysis Copyright 2003, SAS Institute Inc. All rights reserved. 27
28 SAS Publications in MicroArray Analysis Drosophila Example from Gibson Lab at NC State Jin et al. (2001) Nature Genetics 29: Copyright 2003, SAS Institute Inc. All rights reserved. 28
29 SAS and FDA Copyright 2003, SAS Institute Inc. All rights reserved. 29
30 SAS and FDA! Used by several FDA centers, including CBER, CDRH, CDER, CFSAN, CVM and NCTR! FDA use of SAS: Data mining for vaccine safety surveillance Creating a toxicology research repository Analyzing chronic disease data to stop the spread of diseases and biological disasters Accessing and analyzing structured and non-structured data! Since 1999 the FDA has specified the use of SAS file format for datasets used in electronic regulatory submissions to the FDA Copyright 2003, SAS Institute Inc. All rights reserved. 30
31 In Conclusion: SAS Scientific Discovery Solutions Empower You To:! Fail early fail cheap, to increase efficiency & minimize risk! Perform proactive research instead of reactive to sustain competitive edge! Promote multidisciplinary view of research programs to minimize time to market! Improve compliance within discovery to reduce regulatory issues downstream Copyright 2003, SAS Institute Inc. All rights reserved. 31
32 SUGI 28: Paper Copyright 2003, SAS Institute Inc. All rights reserved. 32
33 Live Demo of RDM and the SAS Microarray Solution tomorrow! Thank you! Copyright 2003, SAS Institute Inc. All rights reserved. 33
34 Copyright 2003, 2003, SAS Institute SAS Institute Inc. All rights Inc. reserved. All rights reserved. 34
Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR)
Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR) Enable Science in silico & Provide the Right Knowledge to the Right People at the Right Time to enable the
Voluntary Genomic Data Submissions at the U.S. FDA
Voluntary Genomic Data Submissions at the U.S. FDA International Conference on Harmonization Chicago, IL November 9-10, 9 2005 Felix W. Frueh, PhD Associate Director for Genomics Office of Clinical Pharmacology
BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16
Course Director: Dr. Barry Grant (DCM&B, [email protected]) Description: This is a three module course covering (1) Foundations of Bioinformatics, (2) Statistics in Bioinformatics, and (3) Systems
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS 1. The Technology Strategy sets out six areas where technological developments are required to push the frontiers of knowledge
Statistics and Data Analysis. Paper 259-28
Paper 259-28 An Introduction to Genomics and SAS Scientific Discovery Solutions Russ Wolfinger, SAS Institute Inc., Cary, NC Kristen Quinlan, SAS Institute Inc., Cary, NC Susan Flood, SAS Institute Inc.,
THE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
Big Data Visualization for Genomics. Luca Vezzadini Kairos3D
Big Data Visualization for Genomics Luca Vezzadini Kairos3D Why GenomeCruzer? The amount of data for DNA sequencing is growing Modern hardware produces billions of values per sample Scientists need to
Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form
C H I Cambridge Healthtech Institute s Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form Over 800,000 names segmented by scientific interest Featuring U.S and International
TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials
TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials Pharmaceutical leader deploys TIBCO Spotfire enterprise analytics platform across its drug discovery organization
A Primer of Genome Science THIRD
A Primer of Genome Science THIRD EDITION GREG GIBSON-SPENCER V. MUSE North Carolina State University Sinauer Associates, Inc. Publishers Sunderland, Massachusetts USA Contents Preface xi 1 Genome Projects:
Toward Acceleration of Open Innovation
Toward Acceleration of Open Innovation ーThe Role of Industrial-Academic- Government-Collaborationー Masafumi Nogimori Representative Director and Chairman Astellas Pharm Inc. International Symposium New
Using the Grid for the interactive workflow management in biomedicine. Andrea Schenone BIOLAB DIST University of Genova
Using the Grid for the interactive workflow management in biomedicine Andrea Schenone BIOLAB DIST University of Genova overview background requirements solution case study results background A multilevel
Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research
Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from
Molecular Genetics: Challenges for Statistical Practice. J.K. Lindsey
Molecular Genetics: Challenges for Statistical Practice J.K. Lindsey 1. What is a Microarray? 2. Design Questions 3. Modelling Questions 4. Longitudinal Data 5. Conclusions 1. What is a microarray? A microarray
Goals & Objectives. Drug Development & the FDA Pharmacy 309. Outline. An History of Disasters. Be able to describe
Drug Development & the FDA Pharmacy 309 Tom Hazlet, Pharm.D., Dr.P.H. 616-2732 thazlet@u... Goals & Objectives Be able to describe the major regulatory events in the drug development process the concepts
University of Glasgow - Programme Structure Summary C1G5-5100 MSc Bioinformatics, Polyomics and Systems Biology
University of Glasgow - Programme Structure Summary C1G5-5100 MSc Bioinformatics, Polyomics and Systems Biology Programme Structure - the MSc outcome will require 180 credits total (full-time only) - 60
Master of Science in Biomedical Sciences
Master of Science in Biomedical Sciences Faculty of Medicine Good health is our greatest treasure. Understanding the human body, healthy and diseased, is the stepping stone to finding tools to improving
Cardiff University MSc in Bioinformatics - MSc in Genetic Epidemiology & Bioinformatics
Cardiff University MSc in Bioinformatics - MSc in Genetic Epidemiology & Bioinformatics http://bbu.cardiff.ac.uk/html/training/msc.htm What is Bioinformatics? Bioinformatics applies principles of information
IEEE International Conference on Computing, Analytics and Security Trends CAST-2016 (19 21 December, 2016) Call for Paper
IEEE International Conference on Computing, Analytics and Security Trends CAST-2016 (19 21 December, 2016) Call for Paper CAST-2015 provides an opportunity for researchers, academicians, scientists and
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences It s not information overload, it s filter failure. Clay Shirky Life Sciences organizations face the challenge
Regulatory Issues in Genetic Testing and Targeted Drug Development
Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
REGULATIONS FOR THE DEGREE OF BACHELOR OF SCIENCE IN BIOINFORMATICS (BSc[BioInf])
820 REGULATIONS FOR THE DEGREE OF BACHELOR OF SCIENCE IN BIOINFORMATICS (BSc[BioInf]) (See also General Regulations) BMS1 Admission to the Degree To be eligible for admission to the degree of Bachelor
BIOINFORMATICS METHODS AND APPLICATIONS
FACULTY of ENGINEERING SCHOOL OF COMPUTER SCIENCE AND ENGINEERING BINF3010/9010 BIOINFORMATICS METHODS AND APPLICATIONS SESSION 1, 2015 Course staff Course Convener: Bruno Gaëta [email protected] School
TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298
DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES MAY 2014. May 2014 ABA 298 1 Technologies, Products & Services
Alison Yao, Ph.D. July 2014
* Alison Yao, Ph.D. Program Officer, Office of Genomics and Advanced Technologies Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes
Big Data Trends A Basis for Personalized Medicine
Big Data Trends A Basis for Personalized Medicine Dr. Hellmuth Broda, Principal Technology Architect emedikation: Verordnung, Support Prozesse & Logistik 5. Juni, 2013, Inselspital Bern Over 150,000 Employees
TRANSFORMING LIFE SCIENCES THROUGH ENTERPRISE ANALYTICS
TRANSFORMING LIFE SCIENCES THROUGH ENTERPRISE HOW SOLUTIONS AND ENTERPRISE ENVIRONMENTS ARE IMPROVING EFFICIENCY AND ENABLING NEW INSIGHTS THROUGHOUT THE LIFE SCIENCES INDUSTRY Matt Gross Director Health
From Data to Foresight:
Laura Haas, IBM Fellow IBM Research - Almaden From Data to Foresight: Leveraging Data and Analytics for Materials Research 1 2011 IBM Corporation The road from data to foresight is long? Consumer Reports
Apply with Resume to: www.rjrt.com Submenu Path Company/Careers/Current Openings/Job Type: Science
Position: Biostatistician Required Experience: At least 5 years This position is responsible for providing broad statistical support in general and biostatistical support specifically, including study
Division of Bioinformatics and Biostatistics
Division of Bioinformatics and Biostatistics Weida Tong, Ph.D. The views presented do not necessarily reflect the views of the FDA. 1 Established on May 20 th, 2012. Three Branches: Division Overview Bioinformatics
Intro to Bioinformatics
Intro to Bioinformatics Marylyn D Ritchie, PhD Professor, Biochemistry and Molecular Biology Director, Center for Systems Genomics The Pennsylvania State University Sarah A Pendergrass, PhD Research Associate
Cell Discovery 360: Explore more possibilities.
Cell Discovery 360: Explore more possibilities. Flexible solutions for the BioPharma laboratory Blood Banking Capillary Electrophoresis Centrifugation Flow Cytometry Genomics Lab Automation Lab Tools Particle
BSc (Hons) Biology (Minor: Forensic Science or Marine & Coastal Environmental Science)/MSc Biology SC516 (Subject to Approval) SC516
BSc (Hons) Biology (Minor: Forensic Science or Marine & Coastal Environmental Science)/MSc Biology SC516 (Subject to Approval) SC516 1. Mission, Aims and Objectives The new BSc (Hons)/ MSc course is a
Course Course Name # Summer Courses DCS Clinical Research 5103 Questions & Methods CORE. Credit Hours. Course Description
Course Course Name # Summer Courses Clinical Research 5103 Questions & Methods Credit Hours Course Description 1 Defining and developing a research question; distinguishing between correlative and mechanistic
Presented at: Jefferies 2015 Global Healthcare Conference
Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution
Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources
1 of 8 11/7/2004 11:00 AM National Center for Biotechnology Information About NCBI NCBI at a Glance A Science Primer Human Genome Resources Model Organisms Guide Outreach and Education Databases and Tools
European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute
European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute Justin Paschall Team Leader Genetic Variation / EGA ! European Genome-phenome
Service courses for graduate students in degree programs other than the MS or PhD programs in Biostatistics.
Course Catalog In order to be assured that all prerequisites are met, students must acquire a permission number from the education coordinator prior to enrolling in any Biostatistics course. Courses are
The National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH
Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH VWR enables the advancement of science by providing high-quality chemicals and services, customized to your
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences WP11 Data Storage and Analysis Task 11.1 Coordination Deliverable 11.2 Community Needs of
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
Using SAS in Clinical Research. Greg Nelson, ThotWave Technologies, LLC.
Using SAS in Clinical Research Greg Nelson, ThotWave Technologies, LLC. Outline Introduction and Overview SAS 30 years of evolution The SAS 9 Platform Clinical Research Imperatives Summary and Conclusions
Big Data An Opportunity or a Distraction? Signal or Noise?
Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28
Fast. Integrated Genome Browser & DAS. Easy. Flexible. Free. bioviz.org/igb
bioviz.org/igb Integrated Genome Browser & DAS Free tools for visualizing, sharing, and publishing genomes and genome-scale data. Easy Flexible Fast Free Funding: National Science Foundation Arabidopsis
An EVIDENCE-ENHANCED HEALTHCARE ECOSYSTEM for Cancer: I/T perspectives
An EVIDENCE-ENHANCED HEALTHCARE ECOSYSTEM for Cancer: I/T perspectives Chalapathy Neti, Ph.D. Associate Director, Healthcare Transformation, Shahram Ebadollahi, Ph.D. Research Staff Memeber IBM Research,
The Moroccan American Pharmaceutical Sciences & Education Network Group (PharMaSeng), University Hassan II MohammediaCasablanca & FST Mohammedia
The Moroccan American Pharmaceutical Sciences & Education Network Group (PharMaSeng), University Hassan II MohammediaCasablanca & FST Mohammedia Organize a Bioinformatic International Workshop October
Cancer Patients Urgently Need Effective, Genetically-Targeted Treatments
Cancer Patients Urgently Need Effective, Genetically-Targeted Treatments The Core Problem One Symptom, Not One Disease The disease we call cancer is the second most common cause of death in the United
October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892
October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies
TRACKS GENETIC EPIDEMIOLOGY
Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that
Technology funding opportunities at the National Cancer Institute
Technology funding opportunities at the National Cancer Institute Through the Cancer Diagnosis Program http://cancerdiagnosis.nci.nih.gov/index.html Avraham Rasooly Ph.D. National Cancer Institute, Cancer
MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015
19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All
FOR TEXTILES. o Kuchipudi-I] textiles. Outdoor Activity Based Courses. Camp
SEMESTER I Basic Sciences Courses o General Chemistry o Biology for Engineers o Fundamentals of Mathematics o Applied Physics-I for Life Science Behavioural Science o Understanding Self for Effectiveness
ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS
ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS INCORPORATE GENOMIC DATA INTO CLINICAL R&D KEY BENEFITS Enable more targeted, biomarker-driven clinical trials Improves efficiencies, compressing
Course Requirements for the Ph.D., M.S. and Certificate Programs
Health Informatics Course Requirements for the Ph.D., M.S. and Certificate Programs Health Informatics Core (6 s.h.) All students must take the following two courses. 173:120 Principles of Public Health
Overview of Phase 1 Oncology Trials of Biologic Therapeutics
Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of
Bachelor Curriculum in cooperation with
K 0/675 Bachelor Curriculum in cooperation with Přírodovědecká fakulta, PRF, Faculty of Science Jihočeská univerzita, University of South Bohemia in Budweis (České Budějovice) Česká republika, Czech Republic
CALIFORNIA STATE UNIVERSITY CHANNEL ISLANDS
CALIFORNIA STATE UNIVERSITY CHANNEL ISLANDS PROGRAM MODIFICATION DATE: 12.06.06 PROGRAM AREA: BIOLOGY AND BUSINESS AND ECONOMICS SEMESTER /YEAR FIRST EFFECTED: FALL 2007 Please use the following format
Smart Monitoring Service
SMART SERVICES Smart Monitoring Service Increase productivity with real-time remote instrument monitoring. Life in the lab just got easier with remote instrument monitoring. When one of your instruments
Dr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
PHYSIOLOGY. THE STUDY OF LIFE, and how genes, cells, tissues, and organisms function.
PHYSIOLOGY THE STUDY OF LIFE, and how genes, cells, tissues, and organisms function. What is PHYSIOLOGY? Physiologists teach and mentor students in both the classroom and laboratory. Physiologists apply
FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS
SMG 1117.2112 FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF INFORMATION MANAGEMENT AND TECHNOLOGY OFFICE OF INFORMATION MANAGEMENT
Automate Data Integration Processes for Pharmaceutical Data Warehouse
Paper AD01 Automate Data Integration Processes for Pharmaceutical Data Warehouse Sandy Lei, Johnson & Johnson Pharmaceutical Research and Development, L.L.C, Titusville, NJ Kwang-Shi Shu, Johnson & Johnson
How To Change Medicine
P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version
Answer Key. Vocabulary Practice
Answer Key Vocabulary Practice Copyright by McDougal Littell, a division of Houghton Mifflin Company A. Categorize Words 1. organism, L; cell, L; species, L; transgenic, B; biotechnology, T; molecular
TERM SHEET EXAMPLE. 1 P age
1 P age TERM SHEET EXAMPLE BIOTECHCO Overview & Business Strategy BIOTECHCO (the licensor), located in North Dakota, has a proprietary technology called ZIP that can generate fully human antibodies with
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE DEFINITIONS FOR GENOMIC BIOMARKERS, PHARMACOGENOMICS,
CCR Biology - Chapter 9 Practice Test - Summer 2012
Name: Class: Date: CCR Biology - Chapter 9 Practice Test - Summer 2012 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Genetic engineering is possible
Delivering the power of the world s most successful genomics platform
Delivering the power of the world s most successful genomics platform NextCODE Health is bringing the full power of the world s largest and most successful genomics platform to everyday clinical care NextCODE
The MSCR Curriculum and Its Advantages
Masters of Science in Clinical Research (MSCR) Curriculum Goal/Objective of the MSCR The MSCR program is an interdisciplinary research degree program housed within the Department of Epidemiology in the
M110.726 The Nucleus M110.727 The Cytoskeleton M340.703 Cell Structure and Dynamics
of Biochemistry and Molecular Biology 1. Master the knowledge base of current biochemistry, molecular biology, and cellular physiology Describe current knowledge in metabolic transformations conducted
How To Get A Masters Degree In Biomedical Informatics
UNIVERSITY OF COLOMBO POSTGRADUATE INSTITUTE OF MEDICINE OF SRI LANKA Drafted and printed by the Board of Study in Multi Disciplinary Study Courses and the Postgraduate Institute of Medicine, University
Data Integration. Lectures 16 & 17. ECS289A, WQ03, Filkov
Data Integration Lectures 16 & 17 Lectures Outline Goals for Data Integration Homogeneous data integration time series data (Filkov et al. 2002) Heterogeneous data integration microarray + sequence microarray
Lecture 11 Data storage and LIMS solutions. Stéphane LE CROM [email protected]
Lecture 11 Data storage and LIMS solutions Stéphane LE CROM [email protected] Various steps of a DNA microarray experiment Experimental steps Data analysis Experimental design set up Chips on catalog
Medicines for Neglected Diseases Workshop. Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia
Medicines for Neglected Diseases Workshop Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia September 11, 2010 Poverty, Many People Poor health conditions High Morbidity
FACULTY OF MEDICAL SCIENCE
Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern
Micromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting -
A Microbiology Services Company Lab Services Research - Consulting - Regulatory Company description is a microbiology services company specializing in antiinfective discovery and development for the pharmaceutical,
AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE
ACCELERATING PROGRESS IS IN OUR GENES AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE GENESPRING GENE EXPRESSION (GX) MASS PROFILER PROFESSIONAL (MPP) PATHWAY ARCHITECT (PA) See Deeper. Reach Further. BIOINFORMATICS
Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se
Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in
What can technology offer
What can technology offer The view from SAS Institute Heléne Spjuth Subject Matter Expert / Healthcare About SAS Our Company The leader in business analytics software and services, delivering THE POWER
Visual Mining for Big Data
Visual Mining for Big Data Big Dive June 21st, 2013 Alessandro Piglia Kairos3D Where do we come from? Kairos3D comes from real-time 3D graphics Serious Games (virtual visits, training for industry operators,
Bachelor Curriculum in cooperation with
K 0/675 Bachelor Curriculum in cooperation with Přírodovědecká fakulta, PRF, Faculty of Science Jihočeská univerzita, University of South Bohemia in Budweis (České Budějovice) Česká republika, Czech Republic
How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA
How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA September 10, 2013 Outline Need for improved science in support of
PRACTICAL APPROACH TO ECOTOXICOGENOMICS
ANNOUNCEMENT PRACTICAL APPROACH TO ECOTOXICOGENOMICS Advanced Workshop Studies in Biology and Applied Biosciences Department of Biology University of Aveiro, 30 April- 4 May 2007 This one-week post-graduate
InSyBio BioNets: Utmost efficiency in gene expression data and biological networks analysis
InSyBio BioNets: Utmost efficiency in gene expression data and biological networks analysis WHITE PAPER By InSyBio Ltd Konstantinos Theofilatos Bioinformatician, PhD InSyBio Technical Sales Manager August
1. Program Title Master of Science Program in Biochemistry (International Program)
1 Program Structure and Specification Master of Science Program in Biochemistry (International Program) Curriculum Last Revised in 2012 for Students Entering in Academic Year 2016 -----------------------------------------
Clinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
Guidance for Industry. 21 CFR Part 11; Electronic. Records; Electronic Signatures. Time Stamps
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Time Stamps Draft Guidance This guidance document is being distributed for comment purposes only. Comments and suggestions
Masters of Science in Clinical Research (MSCR) Curriculum. Goal/Objective of the MSCR
Masters of Science in Clinical (MSCR) Curriculum Goal/Objective of the MSCR The MSCR program is an interdisciplinary research degree program housed within the Department of Epidemiology in the School of
Factors Influencing LC/MS/MS Moving into Clinical and Research Laboratories
Factors Influencing LC/MS/MS Moving into Clinical and Research Laboratories Matthew Clabaugh, Market Development AACC Workshop St. Louis, MO September 17,18 2013 Factors Influencing LCMSMS Moving into
